Testing Trametinib as a Potential Targeted Treatment in Cancers With NF1 Genetic Changes (MATCH-Subprotocol S1)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
Mayo Clinic
Wake Forest University Health Sciences
Memorial Sloan Kettering Cancer Center
Pfizer
Pfizer
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
Massachusetts General Hospital
Medical College of Wisconsin
University of Chicago
University of Chicago
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Pfizer
Thomas Jefferson University
Pfizer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Washington University School of Medicine
University of Washington
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Brown University
GlaxoSmithKline
National Cancer Institute (NCI)
Weill Medical College of Cornell University
Mayo Clinic
Amgen
GlaxoSmithKline
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Emory University
Mayo Clinic
City of Hope Medical Center